Scarica l'app Stockscreener
13.43
0.37%
-2.482
Precedente Chiudi:
$10.95
Aprire:
$13.4
Volume 24 ore:
1,877
Relative Volume:
66.00
Capitalizzazione di mercato:
$N/A
Reddito:
$614.00K
Utile/perdita netta:
$-76.35M
Rapporto P/E:
-0.282
EPS:
-47.63
Flusso di cassa netto:
$-31.51M
1 W Prestazione:
-0.37%
1M Prestazione:
-56.83%
6M Prestazione:
-76.92%
1 anno Prestazione:
+245.37%
Intervallo 1D:
$13.40
$13.43
Intervallo di 1 settimana:
$13.40
$13.43
Portata 52W:
$13.40
$13.43
Finch Therapeutics Group Inc Stock (FNCH) Company Profile
Nome
Finch Therapeutics Group Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta FNCH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FNCH
Finch Therapeutics Group Inc
|
13.43 | 0 | 614.00K | -76.35M | -31.51M | -47.63 |
|
VRTX
Vertex Pharmaceuticals Inc
|
448.37 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
513.54 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
312.32 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
537.92 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
252.78 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Finch Therapeutics Group Inc Stock (FNCH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-08-09 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-13 | Iniziato | BofA Securities | Buy |
| 2021-04-13 | Iniziato | Evercore ISI | Outperform |
| 2021-04-13 | Iniziato | Jefferies | Buy |
Finch Therapeutics Group Inc Borsa (FNCH) Ultime notizie
Clostridium Difficile Infections Pipeline 2025: MOA and ROA - openPR.com
Winchester Bancorp, Inc./MD/’s (NASDAQ:WSBK) Quiet Period Set To End on June 11th - Defense World
Reviewing Finch Therapeutics Group (NASDAQ:FNCH) and Mesoblast (NASDAQ:MESO) - Defense World
CBL International (NASDAQ:BANL) Initiates Share Buyback Plan - Defense World
5 Best Microbiome Companies (June 2025) - Securities.io
Finch Therapeutics Group (NASDAQ:FNCH) Trading Up 5.4% – Still a Buy? - Defense World
Ameriprise Financial Inc. Sells 3,274 Shares of iShares Agency Bond ETF (NYSEARCA:AGZ) - Defense World
Virpax Pharmaceuticals (NASDAQ:VRPX) Trading 4.4% Higher – Still a Buy? - Defense World
Hydrofarm Holdings Group (NASDAQ:HYFM) Stock Price Up 8.2% – Here’s Why - Defense World
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $9.40 Consensus PT from Brokerages - Defense World
Bank of America Corp DE Has $10.76 Million Stock Holdings in Amer Sports, Inc. (NYSE:AS) - Defense World
Fecal Transplant Treatment Market: Manufacturer Capacity, Output, Sales, Competition Analysis Report 2025 - openPR.com
Live Biotherapeutic Product Market Growth Driven by Digestive - openPR.com
Price T Rowe Associates Inc. MD Purchases 6,966 Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - Defense World
Head to Head Contrast: Crimson Wine Group (OTCMKTS:CWGL) versus Eastside Distilling (NASDAQ:BLNE) - Defense World
Life360 (NASDAQ:LIF) versus Workday (NASDAQ:WDAY) Head-To-Head Comparison - Defense World
Finch Therapeutics Group (NASDAQ:FNCH) and Quince Therapeutics (NASDAQ:QNCX) Head to Head Comparison - Defense World
Clostridium Difficile Infections Clinical Trials 2025: EMA, - openPR.com
Stifel Financial Corp Acquires 1,495 Shares of Iridium Communications Inc. (NASDAQ:IRDM) - Defense World
Dimensional Fund Advisors LP Has $4.56 Million Position in Red River Bancshares, Inc. (NASDAQ:RRBI) - Defense World
Alvotech (ALVO) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Microbiome Therapeutic Market Poised to Reach USD 3,121.8 Million by 2035, Growing at a CAGR of 14.2% - openPR.com
Raymond James Financial Inc. Acquires Shares of 6,760 Kodiak Gas Services, Inc. (NYSE:KGS) - Defense World
Dimensional Fund Advisors LP Has $10.38 Million Stock Position in Ero Copper Corp. (NYSE:ERO) - Defense World
StockNews.com Downgrades Myriad Genetics (NASDAQ:MYGN) to Hold - Defense World
Raymond James Financial Inc. Takes $554,000 Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
H-CYTE (OTCMKTS:HCYTD) Stock Price Down 49.5% – What’s Next? - Defense World
Calamos Long/Short Equity & Dynamic Income Term Trust (NASDAQ:CPZ) Short Interest Down 15.0% in April - Defense World
Clostridium Difficile Infections Pipeline and Clinical Trials - openPR.com
Arquitos Capital's Largest Holdings For Q1 2025 - Seeking Alpha
Arquitos Capital Management Q1 2025 Investor Letter - Seeking Alpha
Global Human Microbiome Market: Exploring Technological Innovations Fueling 31% CAGR Growth by 2030 - PharmiWeb.com
Prosperity Bancshares (PB) Expected to Announce Quarterly Earnings on Wednesday - American Banking and Market News
Vanguard Group Inc. Increases Stake in Westrock Coffee (NASDAQ:WEST) - Defense World
Financial Contrast: Kiromic BioPharma (NASDAQ:KRBP) and Finch Therapeutics Group (NASDAQ:FNCH) - Defense World
Clostridium Difficile Infections Pipeline 2025: MOA, ROA, - openPR.com
Rising Prevalence Of Gastrointestinal Disorders Growth In Fecal Microbiota Transplantation (FMT) Market: A ... - WhaTech
Procaps Group (NASDAQ:PROC) Stock Price Down 40.3% – Time to Sell? - Defense World
Finch Therapeutics Group (NASDAQ:FNCH) Stock Price Up 1.5% – Still a Buy? - Defense World
Wickes Group (LON:WIX) Trading Down 0.2% – What’s Next? - Defense World
TechBio and Microbiome (III) - substack.com
Microbiome Disease Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 140+ Companies and 180+ Therapies | DelveInsight - GlobeNewswire
Microbiome Disease Clinical Trial Analysis: Key Insights - GlobeNewswire
(PDF) Global Human Microbiome Market: The Impact of Lifestyle Diseases on the Projected 31% CAGR Growth by 2030 - ResearchGate
Finch Therapeutics Group (NASDAQ:FNCH) Trading Down 0.3% – What’s Next? - Defense World
Innovent Biologics (OTCMKTS:IVBXF) Shares Down 0.2% – Here’s Why - Defense World
Scheid Vineyards (OTCMKTS:SVIN) Stock Price Down 5.3% – What’s Next? - Defense World
Thunderbird Entertainment Group (OTCMKTS:THBRF) Stock Price Down 5.9% – Here’s Why - Defense World
COSCO SHIPPING (OTCMKTS:CICOF) Trading Up 9.7% – Here’s What Happened - Defense World
Clostridium Difficile Infections Clinical Trials and Pipeline - openPR
Ulcerative Colitis Clinical Trials and Drugs 2025: EMA, PDMA, - openPR
Finch Therapeutics Group Inc Azioni (FNCH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.32%
0.98%
Capitalizzazione:
|
Volume (24 ore):